The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis

详细信息    查看全文

• 作者：Alberto M. Martelli ; Camilla Evangelisti ; Francesca Chiarini ; Cecilia Grimaldi ; Aless ; ra Cappellini ; Andrea Ognibene ; James A. McCubrey
• 关键词：PI3K/Akt/mTOR ; Hematopoietic stem cell ; Signal transduction ; Proliferation ; Differentiation ; Leukemia
• 刊名：Biochimica et Biophysica Acta (BBA)/Molecular Cell Research
• 出版年：2010
• 出版时间：September 2010
• 年：2010
• 卷：1803
• 期：9
• 页码：991-1002
• 全文大小：841 K

文摘

The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway mediates diverse and important physiological cell functions which include proliferation, differentiation, survival, motility, autophagy, and metabolism. However, dysregulated PI3K/Akt/mTOR signaling has been documented in a wide range of neoplasias, including malignant hematological disorders. It is now emerging that this signaling network plays a key role during normal hematopoiesis, a tightly regulated process resulting in the formation of all blood lineages. Blood cell development encompasses a complex series of events which are mainly regulated by actions of cytokines, a family of extracellular ligands which stimulate many biological responses in a wide array of cell types. Hematopoiesis is strictly dependent on the correct function of the bone marrow microenvironment (BMM), as BMM cells secrete most of the cytokines. Several of these cytokines activate the PI3K/Akt/mTOR signaling network and regulate proliferation, survival, and differentiation events during hematopoiesis. Here, we review the evidence that links the signals emanating from the PI3K/Akt/mTOR cascade with the functions of hematopoietic stem cells and the process of myelopoiesis, including lineage commitment. We then highlight the emerging role played by aberrant PI3K/Akt/mTOR signaling during leukemogenesis.